EMA Authorised: Tenkasi (previously Orbactiv) (oritavancin (diphosphate)) — Menarini International Operations Luxembourg S.A.

View source ↗

Summary

The European Medicines Agency has authorised Tenkasi (oritavancin diphosphate) by Menarini International Operations Luxembourg S.A. for soft tissue infections a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin Infection
• Soft Tissue Infection

Drugs mentioned

• Tenkasi (oritavancin (diphosphate))

Snippet

Status: Authorised. Therapeutic area: Soft Tissue Infections;Skin Diseases, Bacterial. MAH: Menarini International Operations Luxembourg S.A.. Decision date: 19/11/2024